EUVIMEDEUVIMED entdecken
Open Access

Magnesium Administration as a Treatment for Perioperative Atrial Fibrillation following Cardiac Surgery: Safety and Efficacy

Takafumi Terada, Yoshiyuki Tokuda, Yoshimori Araki, Akihiro Kobayashi, Osamu Kawaguchi, Eriko Koike, Masato Mutsuga

Annals of Thoracic and Cardiovascular Surgery · 2026

DOI: 10.5761/atcs.oa.26-00129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Takafumi Terada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anti-Arrhythmia Agents, Heart Rate, Cardiac Surgical Procedures. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Atrial fibrillation (AF) is a common complication after cardiac surgery, impacting recovery and outcomes. Magnesium has electrophysiological and rate-controlling effects in AF. This study evaluated the safety and the temporal association between therapeutic intravenous magnesium administration and rhythm outcomes in patients with postoperative atrial fibrillation (POAF) after cardiac surgery. METHODS: Between January 2009 and December 2016, 714 patients undergoing cardiac surgery were evaluated. After excluding 49 patients with a history of AF, 130 developed new-onset POAF. Of these, 111 patients (85.4%) received intravenous magnesium according to our institutional protocol, whereas 19 patients (14.6%) did not. Magnesium (20 mEq per dose, 1-3 doses) was administered with other antiarrhythmic agents in 40 patients (36.0%) and as monotherapy in 71 patients (64.0%). The principal efficacy analyses were restricted to the magnesium-monotherapy cohort. Serum magnesium levels after administration were monitored in 35 patients. RESULTS: Among the 71 patients treated with magnesium monotherapy, the heart rate significantly decreased from 114 ± 32.3 bpm to 100 ± 39.7 bpm (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnti-Arrhythmia AgentsHeart RateCardiac Surgical ProceduresMagnesiumHumansFemaleMaleTreatment OutcomeAgedTime FactorsRisk FactorsMiddle AgedRetrospective StudiesInfusions, IntravenousAdministration, Intravenous

Stichwörter der Autor:innen

magnesium therapyperioperative atrial fibrillation

Substanzen

Anti-Arrhythmia AgentsMagnesium

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Department of Cardiac Surgery, JA Aichi Koseiren Toyota Kosei Hospital, Toyota, Aichi, Japan.

Zitieren

APA

Terada, T., Tokuda, Y., Araki, Y., Kobayashi, A., Kawaguchi, O., Koike, E., & Mutsuga, M. (2026). Magnesium Administration as a Treatment for Perioperative Atrial Fibrillation following Cardiac Surgery: Safety and Efficacy. Annals of Thoracic and Cardiovascular Surgery. https://doi.org/10.5761/atcs.oa.26-00129

Vancouver

Terada T, Tokuda Y, Araki Y, Kobayashi A, Kawaguchi O, Koike E, et al. Magnesium Administration as a Treatment for Perioperative Atrial Fibrillation following Cardiac Surgery: Safety and Efficacy. Annals of Thoracic and Cardiovascular Surgery. 2026. doi:10.5761/atcs.oa.26-00129

BibTeX
@article{Terada2026,
  author = {Terada, Takafumi and Tokuda, Yoshiyuki and Araki, Yoshimori and Kobayashi, Akihiro and Kawaguchi, Osamu and Koike, Eriko and Mutsuga, Masato},
  title = {Magnesium Administration as a Treatment for Perioperative Atrial Fibrillation following Cardiac Surgery: Safety and Efficacy},
  journal = {Annals of Thoracic and Cardiovascular Surgery},
  year = {2026},
  doi = {10.5761/atcs.oa.26-00129}
}
Kostenlos starten →